세계의 미주신경성 실신 치료 시장 보고서(2025년)

Vasovagal Syncope Treatment Global Market Report 2025

US $ 4,490 ￦ 6,138,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,872,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,606,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

미주신경성 실신 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.2%의 성장률(CAGR)로 21억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료의 발전, 신경심인성 메커니즘에 대한 관심 증가, 심리적 요인에 대한 인식 증가, 다학제적 치료의 통합 발전, 사회적 인식 증가 등의 요인에 기인하는 것으로 보입니다. 이 기간의 주요 동향으로는 디지털 헬스 툴의 통합, 다학제 진료의 지속, 약리학적 혁신, 웨어러블 기술 및 원격 모니터링, 인공지능(AI) 및 머신러닝의 활용 등이 있습니다.

심혈관질환의 유병률 증가는 미주신경성 실신 치료 시장의 확대를 촉진할 것으로 예상됩니다. 심혈관질환에는 심장병, 고혈압, 뇌졸중, 부정맥 등 심장과 혈관에 영향을 미치는 다양한 질환이 포함됩니다. 이러한 문제는 주로 가공식품, 포화지방, 고나트륨 과다 섭취와 같은 건강에 해로운 식습관으로 인해 발생하며, 고혈압, 비만, 고콜레스테롤과 같은 상태를 유발하며, 이 모든 것이 심장병의 위험을 크게 증가시킵니다. 미주신경성 실신 치료는 혈압을 안정시키고, 자율신경 조절을 개선하고, 실신과 주요 장기로의 혈류 감소를 유발하는 심박수의 급격한 감소를 방지하여 심혈관계 문제를 관리하는 데 도움이 됩니다. 예를 들어, 2025년 1월 미국심장협회에 따르면 2022년 미국 내 사망자 수는 94만 1,652명으로 전년 대비 1만 명 이상 증가한 것으로 나타났습니다. 결과적으로 심혈관질환의 증가가 혈관성 실신 치료 시장의 성장에 기여하고 있습니다.

원격의료 서비스의 확대는 미주신경성 실신 치료 시장의 성장을 더욱 촉진할 것으로 예상됩니다. 원격의료 서비스는 화상 통화, 전화, 온라인 플랫폼 등 디지털 통신 기술을 활용하여 원격으로 의료 서비스를 제공하는 것으로, 환자는 의료기관을 방문하지 않고도 의료 전문가와 상담할 수 있습니다. 이러한 확대는 편리한 의료 서비스 이용에 대한 수요 증가에 따른 것으로, 더 많은 환자들이 원격진료를 원하고 있으며, 특히 지방이나 의료 서비스가 부족한 지역에서 대면 진료의 필요성을 줄이고 더 높은 유연성을 제공하기 위해 원격진료에 대한 요구가 증가하고 있습니다. 미주신경성 실신 치료는 원격 모니터링, 가상 진료, 적시 개입, 접근성 및 개별화된 치료를 개선함으로써 원격의료 서비스의 혜택을 누리고 있습니다. 예를 들어, Rock Health가 2023년 2월에 실시한 설문조사에 따르면, 응답자의 80%가 원격의료 서비스를 이용한 경험이 있으며, 이는 2021년 대비 8% 포인트 증가한 수치입니다. 따라서 원격의료 서비스의 확대가 미주신경성 실신 치료 시장의 성장을 가속화하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 미주신경성 실신 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 미주신경성 실신 치료 시장 : 성장률 분석
• 세계의 미주신경성 실신 치료 시장 실적 : 규모와 성장, 2019-2024
• 세계의 미주신경성 실신 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 미주신경성 실신 치료 전체 시장(TAM)

제6장 시장 세분화

• 세계의 미주신경성 실신 치료 시장 치료 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 약
• 라이프스타일 변경
• 외과적 개입
• 심리요법
• 세계의 미주신경성 실신 치료 시장 진단 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 심전도
• 경사 테이블 테스트
• 전기생리학적 연구
• 세계의 미주신경성 실신 치료 시장 환자 연령층별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 소아과
• 성인용
• 노인
• 세계의 미주신경성 실신 치료 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 심장성
• 신경학적
• 대사
• 혈관운동
• 기타 용도
• 세계의 미주신경성 실신 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 전문 클리닉
• 가
• 헬스케어
• 세계의 미주신경성 실신 치료 시장, 의약품 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 처방약
• 시판약(OTC)
• 허브약 또는 대체약
• 주사 또는 점적
• 세계의 미주신경성 실신 치료 시장 라이프스타일 변경 하위 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 식생활 변화
• 신체 활동
• 수면 위생
• 스트레스 관리
• 물질 회피
• 세계의 미주신경성 실신 치료 시장, 외과적 개입 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 최소침습 수술
• 주요 외과수술
• 미용성형
• 비만 수술
• 정형외과 수술
• 세계의 미주신경성 실신 치료 시장 심리요법 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 인지 행동 치료(CBT)
• 정신역동적 요법
• 변증법적 행동치료(DBT)
• 대인관계 요법(IPT)
• 집단요법
• 가족 요법
• 지지요법
• 유희 요법

제7장 지역별·국가별 분석

• 세계의 미주신경성 실신 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 미주신경성 실신 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 미주신경성 실신 치료 시장 : 경쟁 구도
• 미주신경성 실신 치료 시장 : 기업 개요
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Medtronic plc
• Gilead Sciences Inc.
• Amgen Inc.
• Siemens Healthineers AG
• Stryker Corporation
• Regeneron Pharmaceuticals Inc.
• C.H. Boehringer Sohn AG & Co. KG
• Boston Scientific Corporation
• Terumo Corporation
• Ipsen S.A.
• Amneal Pharmaceuticals Inc.
• Mallinckrodt plc
• Biotronik SE & Co. KG
• AtriCure Inc.
• Impax Laboratories Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 미주신경성 실신 치료 시장 2029 : 새로운 기회를 제공하는 국가
• 미주신경성 실신 치료 시장 2029 : 새로운 기회를 제공하는 부문
• 미주신경성 실신 치료 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Vasovagal syncope (VVS) is a common type of fainting caused by the body's exaggerated response to triggers such as stress, pain, prolonged standing, or heat exposure. This condition occurs due to a sudden drop in heart rate and blood pressure, which leads to reduced blood flow to the brain and temporary loss of consciousness.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary treatment options for vasovagal syncope include medication, lifestyle changes, surgical procedures, and psychological therapy. Medication involves using pharmaceutical agents to treat, control, or prevent diseases and symptoms. Diagnosis is conducted through electrocardiograms, tilt table tests, and electrophysiological studies, applicable to various age groups, including pediatric, adult, and geriatric populations. These treatments are employed for a range of conditions, including cardiogenic, neurological, metabolic, and vasomotor disorders, and are utilized across different healthcare settings, such as hospitals, specialty clinics, and home healthcare environments.

The vasovagal syncope treatment market research report is one of a series of new reports from The Business Research Company that provides vasovagal syncope treatment market statistics, including the vasovagal syncope treatment global market size, regional shares, competitors with the vasovagal syncope treatment market share, detailed vasovagal syncope treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the vasovagal syncope treatment. This vasovagal syncope treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vasovagal syncope treatment market size has grown strongly in recent years. It will grow from$1.58 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth during the historical period can be attributed to factors such as the growing use of pharmacological interventions, increasing interest in personalized treatment, a rising number of healthcare professionals, a better understanding of autonomic regulation and the vagus nerve, and improved access to healthcare and treatments.

The vasovagal syncope treatment market size is expected to see strong growth in the next few years. It will grow to$2.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth during the forecast period can be attributed to factors such as advancements in personalized medicine, a growing focus on neurocardiogenic mechanisms, increased awareness of psychological factors, greater integration of multidisciplinary care, and rising public awareness. Key trends during this period include the integration of digital health tools, continued multidisciplinary care, pharmacological innovations, wearable technology and remote monitoring, as well as the use of artificial intelligence (AI) and machine learning.

The growing prevalence of cardiovascular issues is expected to drive the expansion of the vasovagal syncope treatment market. Cardiovascular issues encompass a variety of conditions affecting the heart and blood vessels, such as heart disease, hypertension, stroke, and arrhythmias. These issues are primarily driven by unhealthy diets, including excessive consumption of processed foods, saturated fats, and high sodium, which lead to conditions such as hypertension, obesity, and high cholesterol, all of which significantly raise the risk of heart disease. Vasovagal syncope treatments help manage cardiovascular issues by stabilizing blood pressure, improving autonomic regulation, and preventing sudden drops in heart rate that can cause fainting and reduced blood flow to vital organs. For example, in January 2025, the American Heart Association reported that in 2022, 941,652 deaths in the U.S. were attributed to cardiovascular disease, showing an increase of over 10,000 compared to the previous year. As a result, the rise in cardiovascular issues is contributing to the growth of the vasovagal syncope treatment market.

The expansion of telehealth services is expected to further drive the growth of the vasovagal syncope treatment market. Telehealth services utilize digital communication technologies such as video calls, phone calls, and online platforms to provide healthcare remotely, allowing patients to consult healthcare professionals without visiting medical facilities. This expansion is fueled by the growing demand for convenient healthcare access, as more patients seek remote consultations, reducing the need for in-person visits and offering greater flexibility, particularly in rural or underserved areas. Vasovagal syncope treatment benefits from telehealth services by enabling remote monitoring, virtual consultations, and timely interventions, improving accessibility and personalized care. For instance, a February 2023 survey by Rock Health revealed that 80% of respondents had used telemedicine services at some point, an increase of 8 percentage points from 2021. Therefore, the expansion of telehealth services is accelerating the growth of the vasovagal syncope treatment market.

The increasing awareness of lifestyle modifications is expected to contribute significantly to the growth of the vasovagal syncope treatment market. Lifestyle modifications, such as improving diet, exercising, managing stress, and getting enough sleep, are key to enhancing overall health and managing various conditions. The growing awareness of these modifications is driven by heightened health concerns, as individuals adopt healthier habits to prevent chronic diseases. Vasovagal syncope treatment includes lifestyle adjustments such as staying hydrated, regulating salt intake, avoiding triggers, and engaging in regular exercise to prevent fainting episodes and improve general health. For example, a July 2023 report from the Office of National Statistics in the UK showed that more than 86.5% of adults in Great Britain made lifestyle changes between May and June 2023 to address environmental concerns. As a result, the growing focus on lifestyle modifications is propelling the growth of the vasovagal syncope treatment market.

Major players in the vasovagal syncope treatment market are Johnson & Johnson, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Siemens Healthineers AG, Stryker Corporation, Regeneron Pharmaceuticals Inc., C.H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Terumo Corporation, Ipsen S.A., Amneal Pharmaceuticals Inc., Mallinckrodt plc, Biotronik SE & Co. KG, AtriCure Inc., and Impax Laboratories Inc.

North America was the largest region in the vasovagal syncope treatment market in 2024. The regions covered in vasovagal syncope treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vasovagal syncope treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vasovagal syncope treatment market consists of revenues earned by entities by providing services such as lifestyle counseling, medication management, device implantation, diagnosis, and evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The vasovagal syncope treatment market also includes sales of beta-blockers, selective serotonin reuptake inhibitors (SSRIs), implantable loop recorders, pacemakers, compression garments, and hydration and electrolyte supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vasovagal Syncope Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vasovagal syncope treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vasovagal syncope treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasovagal syncope treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Method: Medication; Lifestyle Modification; Surgical Intervention; Psychological Therapy
• 2) By Diagnosis Type: Electrocardiogram; Tilt Table Test; Electrophysiological Study
• 3) By Patient Age Group: Pediatric; Adult; Geriatric
• 4) By Application: Cardiogenic; Neurological; Metabolic; Vasomotor; Other Applications
• 5) By End User: Hospitals; Specialty Clinics; Home; Healthcare
• Subsegments:
• 1) By Medication: Prescription Drugs; Over-The-Counter (OTC) Medications; Herbal Or Alternative Medications; Injections Or Infusions
• 2) By Lifestyle Modification: Dietary Changes; Physical Activity; Sleep Hygiene; Stress Management; Substance Avoidance
• 3) By Surgical Intervention: Minimally Invasive Surgeries; Major Surgical Procedures; Cosmetic Surgery; Bariatric Surgery; Orthopedic Surgeries
• 4) By Psychological Therapy: Cognitive Behavioral Therapy (CBT); Psychodynamic Therapy; Dialectical Behavior Therapy (DBT); Interpersonal Therapy (IPT); Group Therapy; Family Therapy; Supportive Therapy; Play Therapy
• Companies Mentioned: Johnson & Johnson; Sanofi S.A.; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vasovagal Syncope Treatment Market Characteristics

3. Vasovagal Syncope Treatment Market Trends And Strategies

4. Vasovagal Syncope Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vasovagal Syncope Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vasovagal Syncope Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vasovagal Syncope Treatment Market Growth Rate Analysis
• 5.4. Global Vasovagal Syncope Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vasovagal Syncope Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vasovagal Syncope Treatment Total Addressable Market (TAM)

6. Vasovagal Syncope Treatment Market Segmentation

• 6.1. Global Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Lifestyle Modification
• Surgical Intervention
• Psychological Therapy
• 6.2. Global Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrocardiogram
• Tilt Table Test
• Electrophysiological Study
• 6.3. Global Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric
• Adult
• Geriatric
• 6.4. Global Vasovagal Syncope Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiogenic
• Neurological
• Metabolic
• Vasomotor
• Other Applications
• 6.5. Global Vasovagal Syncope Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Home
• Healthcare
• 6.6. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Drugs
• Over-The-Counter (Otc) Medications
• Herbal Or Alternative Medications
• Injections Or Infusions
• 6.7. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Lifestyle Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Changes
• Physical Activity
• Sleep Hygiene
• Stress Management
• Substance Avoidance
• 6.8. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Minimally Invasive Surgeries
• Major Surgical Procedures
• Cosmetic Surgery
• Bariatric Surgery
• Orthopedic Surgeries
• 6.9. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Psychological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy (CBT)
• Psychodynamic Therapy
• Dialectical Behavior Therapy (DBT)
• Interpersonal Therapy (IPT)
• Group Therapy
• Family Therapy
• Supportive Therapy
• Play Therapy

7. Vasovagal Syncope Treatment Market Regional And Country Analysis

• 7.1. Global Vasovagal Syncope Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vasovagal Syncope Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vasovagal Syncope Treatment Market

• 8.1. Asia-Pacific Vasovagal Syncope Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vasovagal Syncope Treatment Market

• 9.1. China Vasovagal Syncope Treatment Market Overview
• 9.2. China Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vasovagal Syncope Treatment Market

• 10.1. India Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vasovagal Syncope Treatment Market

• 11.1. Japan Vasovagal Syncope Treatment Market Overview
• 11.2. Japan Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vasovagal Syncope Treatment Market

• 12.1. Australia Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vasovagal Syncope Treatment Market

• 13.1. Indonesia Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vasovagal Syncope Treatment Market

• 14.1. South Korea Vasovagal Syncope Treatment Market Overview
• 14.2. South Korea Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vasovagal Syncope Treatment Market

• 15.1. Western Europe Vasovagal Syncope Treatment Market Overview
• 15.2. Western Europe Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vasovagal Syncope Treatment Market

• 16.1. UK Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vasovagal Syncope Treatment Market

• 17.1. Germany Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vasovagal Syncope Treatment Market

• 18.1. France Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vasovagal Syncope Treatment Market

• 19.1. Italy Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vasovagal Syncope Treatment Market

• 20.1. Spain Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vasovagal Syncope Treatment Market

• 21.1. Eastern Europe Vasovagal Syncope Treatment Market Overview
• 21.2. Eastern Europe Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vasovagal Syncope Treatment Market

• 22.1. Russia Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vasovagal Syncope Treatment Market

• 23.1. North America Vasovagal Syncope Treatment Market Overview
• 23.2. North America Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vasovagal Syncope Treatment Market

• 24.1. USA Vasovagal Syncope Treatment Market Overview
• 24.2. USA Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vasovagal Syncope Treatment Market

• 25.1. Canada Vasovagal Syncope Treatment Market Overview
• 25.2. Canada Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vasovagal Syncope Treatment Market

• 26.1. South America Vasovagal Syncope Treatment Market Overview
• 26.2. South America Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vasovagal Syncope Treatment Market

• 27.1. Brazil Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vasovagal Syncope Treatment Market

• 28.1. Middle East Vasovagal Syncope Treatment Market Overview
• 28.2. Middle East Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vasovagal Syncope Treatment Market

• 29.1. Africa Vasovagal Syncope Treatment Market Overview
• 29.2. Africa Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vasovagal Syncope Treatment Market Competitive Landscape And Company Profiles

• 30.1. Vasovagal Syncope Treatment Market Competitive Landscape
• 30.2. Vasovagal Syncope Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Vasovagal Syncope Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Gilead Sciences Inc.
• 31.3. Amgen Inc.
• 31.4. Siemens Healthineers AG
• 31.5. Stryker Corporation
• 31.6. Regeneron Pharmaceuticals Inc.
• 31.7. C.H. Boehringer Sohn AG & Co. KG
• 31.8. Boston Scientific Corporation
• 31.9. Terumo Corporation
• 31.10. Ipsen S.A.
• 31.11. Amneal Pharmaceuticals Inc.
• 31.12. Mallinckrodt plc
• 31.13. Biotronik SE & Co. KG
• 31.14. AtriCure Inc.
• 31.15. Impax Laboratories Inc.

32. Global Vasovagal Syncope Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vasovagal Syncope Treatment Market

34. Recent Developments In The Vasovagal Syncope Treatment Market

35. Vasovagal Syncope Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Vasovagal Syncope Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vasovagal Syncope Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vasovagal Syncope Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r35015_Vasovagal_Syncope_Treatment_GMR_2025